Secondaries announced 5.9.2016
IPOBoutique.Com rates secondary offerings to hit the tape with a ‘BUY’, ‘NEUTRAL’ or ‘AVOID’ rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary’s he’s issued with a ‘BUY’ rating. Company: Asterias Biotherapeutics, Inc. Symbol: AST Price: Last trade $4.33 Description: Re-offer $3.40 Trade Date: 5/10 Shares: 4 million Underwriter(s) Raymond James[…]